CD274 and nonpapillary renal cell carcinoma: We reanalyzed two independent publicly available ccRCC scRNA-seq datasets [Bi’s dataset (14) and Au’s dataset (12)], which were both from ccRCC patients treated with PD-1/PD-L1 monoclonal antibodies.